Mode
Text Size
Log in / Sign up
Phase 2 Completed N=51 Randomized Quadruple-blind Treatment

Beta-blockade Effects on Memory for Cocaine Craving

Cocaine Dependence
Source: ClinicalTrials.gov NCT00830362 ↗
Enrolled (actual)
51
Serious AEs
0.0%
Results posted
Nov 2012
Primary outcomePrimary: Single Item Craving Test Session Difference Scores — -25.0; -10.5 units on a scale

Summary

The purpose of this study is to examine the effects of propranolol versus placebo on responses to cocaine cues in cocaine dependent individuals.

Outcome Measures

OutcomeResultp-value
PRIMARY
Single Item Craving Test Session Difference Scores
-25.0; -10.5

Eligibility Criteria

Inclusion Criteria

  • Current cocaine dependence (within past month)
  • Able to provide informed consent
  • Use of birth control by female participants (barrier methods, surgical sterilization, IUD, or abstinence)
  • Live within 50-mile radius of research site
  • Consent to remain abstinent from all drugs of abuse (except nicotine) for 24 hours prior to inpatient admission and follow-up assessment
  • Consent to random assignment to propranolol or placebo

Exclusion Criteria

  • Women who are pregnant, nursing or are of childbearing potential and not practicing/using birth control
  • Evidence or history of significant hematological, endocrine, cardiovascular, pulmonary, renal, gastrointestinal or neurological disease
  • Significant liver impairment
  • History of or current psychotic disorder, current severe major depressive disorder, bipolar affective disorder or a severe anxiety disorder
  • Currently taking anti-arrhythmic agents, psychostimulants or other agents known to interfere with heart rate and skin conductance monitoring
  • Known or suspected hypersensitivity to propranolol
  • Individuals taking medications that could adversely interact with the study medication, including, but not limited to albuterol, insulin, or significant inhibitors of CYP2D6
  • Individuals with bronchial asthma or chronic obstructive pulmonary disease
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00830362). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search